In Brief
Using CRISPR/Cas9-based screening, Minton et al. identify serine catabolic enzyme SHMT2 as differentially required in low glucose. Via SHMT2, serine contributes to mitochondrial one-carbon pools, THF-based cofactors required for carbon transfer reactions including mitochondrial initiator tRNA formylation. Therefore, SHMT2 loss impacts mitochondrial translation, depleting mitochondrially encoded proteins and decreasing respiration.
INTRODUCTION
Restriction of glucose, either by growth in glucose-limited conditions or by providing alternative, slowly metabolized carbon sources such as galactose, increases the dependence of cells on genes involved in mitochondrial oxidative phosphorylation (OXPHOS) (Arroyo et al., 2016; Birsoy et al., 2014; Robinson et al., 1992) . Mutation of such genes frequently underlies mitochondrial disease in human patients, such as Leigh syndrome, and loss of mitochondrial complex expression or respiration has been observed in several aging-associated diseases, such as neurodegeneration, stem cell exhaustion, and cancer (Wallace, 1999) . Furthermore, growing tumors experience glucose limitation due to a combination of inadequate vasculature and excessive cell proliferation (Gullino et al., 1967; Hirayama et al., 2009) . The ability of cancer cells to survive in such a metabolically challenging environment is likely to be a key adaptation in cancer, which can create novel targetable metabolic liabilities (Cantor and Sabatini, 2012; Vander Heiden and DeBerardinis, 2017) . Therefore, to identify genes required for mitochondrial respiration and survival in low glucose, we previously developed a continuous flow cell culture system termed a nutrostat, enabling extended cell proliferation in glucose-limiting conditions (Birsoy et al., 2014) . We used this system to perform an RNAi-based loss-of-function screen, resulting in the identification of multiple core subunits of OXPHOS and glucose transporters as differentially required in low glucose (Birsoy et al., 2014) . Here, we extend these findings using CRISPR/Cas9-based screening methods and surprisingly identify the onecarbon metabolism enzyme SHMT2 as required for proliferation in a low-glucose environment.
SHMT2 catalyzes the first of a series of four reactions comprising mitochondrial one-carbon metabolism (Ducker and Rabinowitz, 2017; Stover and Schirch, 1990) . The bifunctional enzymes encoded by MTHFD2/2L, as well as MTHFD1L, catalyze the remaining steps providing serine-derived one-carbon units for cytoplasmic reactions requiring a tetrahydrofolate (THF)-coupled methyl donor, such as thymidine synthesis, methionine recycling, and purine synthesis. Eukaryotes maintain a parallel pathway in the cytoplasm catalyzed by enzymes encoded by SHMT1 and the trifunctional MTHFD1, revealing a high degree of metabolic compartmentalization (Appling, 1991) . Interestingly, mice lacking SHMT1 have no overt phenotype, whereas loss of MTHFD2 or MTHFD1L is embryonic lethal, leading to the conclusion that the mitochondrial SHMT2 could compensate for loss of the cytoplasmic SHMT1, and that carbon-charged THF cofactors produced in the cytoplasm could not pass through the mitochondrial membrane to overcome deficits in the mitochondrial compartment (Di Pietro et al., 2002; MacFarlane et al., 2008; Momb et al., 2013) . Surprisingly, enzymes of mitochondrial one-carbon metabolism are frequently silenced or poorly expressed in non-proliferative adult tissues, but become highly upregulated upon initiation of cell proliferation (Mejia and MacKenzie, 1985; Nilsson et al., 2014) . These observations have led to the conclusion that one primary route of serine catabolism in proliferative cells is via harvesting of its carbon by mitochondrial one-carbon metabolism, followed by the export of these one-carbon units to the cytoplasm for use in the above-mentioned reactions. Here, we describe the key role of SHMT2 and mitochondrial one-carbon metabolism in supporting cellular proliferation in low-glucose conditions. SHMT2 null cells exhibit defects in mitochondrial respiration and a corresponding loss of proteins translated in the mitochondria, without effects on cytoplasmic translation. Using cell-based models in which additional enzymes of one-carbon metabolism have been deleted, we conclude that loss of THF-conjugated one-carbon units from the mitochondria underlies the observed SHMT2 knockout phenotype. Specifically, we find that SHMT2 deletion results in loss of the product of a tRNA formylation reaction, fMet-tRNA Met , catalyzed by the enzyme MTFMT and requiring 10-formyl THF as a formyl donor. This modified tRNA is used to initiate translation specifically in mitochondria, and its loss is observed in patients with mitochondrial disease.
RESULTS
A CRISPR/Cas9-Based Genetic Screen Identifies SHMT2 as Differentially Required in Low-Glucose Conditions In previous studies, we used RNAi-based genetic screening approaches in Jurkat leukemic T cells to define a set of genes differentially required in low-glucose conditions, maintained using a continuous flow cell culture system termed a nutrostat (Birsoy et al., 2014) . Here, we replicated this approach using CRISPR/Cas9-based screening methods to compare the two methods and determine if additional differentially required genes would be revealed by using an approach that has the capacity to generate a complete loss of function ( Figure 1A ). We used an analogous small guide RNA (sgRNA) library containing 30,000 sgRNAs targeting 2,948 metabolic enzymes and small molecule transporters (10 sgRNAs/gene) as well as 500 control sgRNAs ( Figure 1A ). Metabolic enzymes were defined as enzymes that act upon small molecules (not upon macromolecules such as proteins, DNA, or RNA), and small molecule transporters were defined as proteins that permit the movement of such small molecules across plasma membranes. We infected Jurkat cells with this sgRNA library, cultured them in nutrostats set to 10 or 0.75 mM glucose-containing RPMI media, and determined the abundance of sgRNAs in the pool at the beginning and end of the culture period by deep sequencing. For each gene, we calculated an essentiality score in these conditions based on the median performance of all 10 sgRNAs (Table S1) .
Similar to the RNAi-based screen, many of the genes selectively required for proliferation in low glucose encode for subunits of the mitochondrial electron transport chain (ETC), particularly Complex I, the components of which scored significantly better than components of Complexes III, IV, or V ( Figures  1B and S1 ). These results further support the observation that the ETC is the major pathway required for optimal proliferation in low glucose. Also identified as differentially required in low glucose are several mitochondrially localized genes including heme biosynthetic enzyme porphobilinogen deaminase (HMBS), a phosphate transporter (SLC25A3), a zinc transporter (SLC30A9), malonyl CoA-acyl carrier protein transacylase (MCAT), Coenzyme Q prenylating enzyme decaprenyl-diphosphate synthase subunit 2 (PDSS2), and StAR-related lipid transfer domain protein 7 (STARD7). These genes are likely required for proper ETC function.
The highest non-ETC scoring gene is the mitochondrial serine hydroxymethyltransferase 2 (SHMT2), which catalyzes the reversible reaction of serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate, directing serine-derived carbon into the one-carbon pool. However, a direct role for mitochondrial one-carbon metabolism in mitochondrial ETC function has not been described. To validate the screening results, we used CRISPR/Cas9-based methods to generate two clonal Jurkat cell lines in which SHMT2 protein was undetectable (sgSHMT2_1 and 2) ( Figures 1C and 1D ). While SHMT2 null cells proliferate more slowly than parental cells in 10 mM glucose, they are particularly sensitive to culture in 1.5 mM glucose ( Figure 1E ). However, these phenotypes were not accompanied by an altered cell-cycle profile and markers of apoptosis or DNA damage were not affected ( Figure S2 ). Reintroduction of SHMT2 into one of the SHMT2 null cell lines by expressing an SHMT2 cDNA restored SHMT2 protein levels and significantly rescued these proliferation defects ( Figures 1C-1E ). To determine whether loss of SHMT2 catalytic activity is required for the observed low glucose sensitivity in the SHMT2 null cell lines, we generated an SHMT2 cDNA in which a key catalytic residue (K280; Schirch et al., 1993) had been mutated to alanine (CD SHMT2). Unlike the wild-type enzyme, the catalytic dead SHMT2 mutant was unable to rescue the effects of SHMT2 deletion on proliferation in high or low glucose ( Figures 1D and 1F) . Therefore, SHMT2 catalytic activity is required for proliferation in low-glucose conditions.
SHMT2 Is Required for Proper Mitochondrial Respiration and Translation of Mitochondrially Encoded Proteins
Given the clear role of the ETC in supporting cell proliferation upon glucose limitation, we considered whether SHMT2 loss could impact cellular respiration. Indeed, we observed a 69.1% reduction in the basal oxygen consumption rate (OCR) of SHMT2 null Jurkat cells and a 68.9% reduction in mitochondrial ATP production compared to parent Jurkat cells (Figures 2A-2C ). Culture in low glucose leads to an increase in the OCR in many cell types as cells adjust to decreased glycolytic flux by increasing mitochondrial oxidation of glucose (Birsoy et al., 2014; Crabtree, 1929) . Similarly, treatment with the ETC uncoupling agent FCCP increases the rate of respiration to the maximum achievable by the cell. In both conditions, SHMT2 null cells exhibited an ability to modestly increase in their OCR, but only to approximately 50% of wild-type levels ( Figure 2A ). We also analyzed intracellular metabolites from SHMT2 null cell lines grown in 10 and 1 mM glucose and noted that the levels of glycine and aspartate were decreased in the mutant cell lines under both glucose conditions ( Figures 2D and S3A ). Glycine is a product of the SHMT2 reaction; hence, reduction in glycine levels is an expected consequence of SHMT2 loss and has been observed upon SHMT2 knockdown by RNAi (Kim et al., 2015) . Interestingly, maintenance of aspartate levels is a key function of the ETC Sullivan et al., 2015) . Thus, the loss of aspartate is consistent with the reduction of oxygen consumption observed upon SHMT2 deletion. However, deficiencies in the levels of these particular amino acids could not themselves explain the effect of SHMT2 deletion on cell proliferation, as their supplementation had no effect on this phenotype ( Figure S3B ).
One hypothesized advantage of the reliance of proliferative cells on mitochondrial serine catabolism is the ability of mitochondrial one-carbon metabolism to generate NADPH, which could be useful in times of high oxidative stress or for the biosynthesis of dNTPs and fatty acids Ye et al., 2014) . We therefore assessed whether the phenotypes observed upon SHMT2 deletion could be the result of defective oxidative stress management. However, we did not observe an increase in overall reactive oxygen species (ROS) as measured by ROS-reactive dyes, nor was antioxidant treatment able to recover any of the proliferative capacity lost upon SHMT2 deletion ( Figures S2 and S3B) .
Based on the significant impairment in respiration upon SHMT2 knockout, we proceeded to assess the underlying cause of the defect. We did not observe substantial changes in mitochondrial DNA (mtDNA) content, mass, or membrane potential in the SHMT2 null cells ( Figures 2E-2G) , and mitochondrial RNA levels were not consistently altered, although modest changes in the abundance of individual regions were observed ( Figures 2H and S3C ). However, upon immunoblotting for mitochondrial proteins, we detected a significant reduction in the levels of mitochondrially encoded cytochrome c oxidase I and II (MT-COI and MT-COII) and NADH-ubiquinone oxidoreductase chain 1 (MT-ND1), but no difference in the levels of nuclearencoded cytochrome c oxidase subunit IV (COX4) ( Figure 2I ). These phenotypes were rescued by the introduction of SHMT2, but not CD SHMT2 (Figures 2I and S3D) . Consistent with these findings, the SHMT2 null cells have reduced synthesis of specific mtDNA-encoded proteins as assayed by [ 35 S]-cysteine and methionine labeling of mitochondrially encoded proteins ( Figure 2J ), similar to previous observations made in patient fibroblasts with defects in mitochondrial translation (Hinttala et al., 2015; Tucker et al., 2011) . In contrast, labeling of proteins translated in the cytosol is not impacted ( Figure 2J ).
To determine if these defects can be observed widely across transformed cell types and species, we chose a panel of cell lines (TT esophageal cancer, MCF10DCIS.com, and MCF-7 breast cancer cell lines, and a cell line, KP, derived from a Kras mutant and Tp53 loss-of-function lung cancer mouse model) and deleted SHMT2 using the sgRNAs described above, or two directed against murine Shmt2 ( Figure S4 ). These SHMT2 null cell lines exhibited a decrease in oxygen consumption and mitochondrially encoded proteins similar to that observed in Jurkat cells, phenotypes rescued by expression of an SHMT2 cDNA (legend continued on next page) ( Figure S4 ). SHMT2 loss was also accompanied by sensitivity to glucose limitation in TT and KP, but not MCF-7 cells, which did not exhibit substantial sensitivity to glucose restriction, or in MCF10DCIS.com cells ( Figure S4 ). Furthermore, these observations extended to cells growing in an in vivo context, as tumors derived from SHMT2 null MCF10DCIS.com cells also exhibited selective loss of mitochondrially encoded proteins ( Figure S4M ).
Collectively, these data demonstrate that SHMT2 is required for proper translation of mitochondrially encoded proteins in multiple contexts.
Depletion of Mitochondrial One-Carbon Units upon SHMT2 Loss Prevents Proper Mitochondrial Translation
One-carbon metabolism takes place in both the cytoplasm and the mitochondria, with parallel reactions taking place in a highly compartmentalized manner ( Figure 3A ). To determine whether the observed impact on mitochondrial respiration and translation is specific to disruption of mitochondrial one-carbon metabolism, we investigated the role of the cytosolic serine hydroxymethyltransferase SHMT1. We overexpressed an SHMT1 cDNA in SHMT2 null Jurkat cells or used CRISPR/Cas9-mediated techniques to generate two SHMT1 null Jurkat cell lines (+sgSHMT1_1 and 2), and verified SHMT1 expression by immunoblotting ( Figure 3B ). Overexpression of SHMT1 in SHMT2 null cells did not rescue the low glucose sensitivity or mitochondrial respiration defects, and did not affect the levels of mitochondrially translated proteins ( Figures 3B-3D ). Similarly, SHMT1 null cells were indistinguishable from parent Jurkat cells with respect to these phenotypes ( Figures 3B-3D ). Therefore, impairment of mitochondrial metabolism and sensitivity to low glucose are specifically the result of losing mitochondrial serine hydroxymethyltransferase activity.
To determine if the effects of deleting SHMT2 on the mitochondria are specifically due to disruption of the efflux of one-carbon units from the mitochondria, we next performed CRISPR/Cas9-mediated deletion of MTHFD1L, the final enzyme in this mitochondrial one-carbon pathway, and verified loss of MTHFD1L by immunoblotting ( Figure 3E ). MTHFD1L catalyzes the reversible conversion of 10-formyl THF to THF and formate, which can exit the mitochondria and contribute to the cytosolic one-carbon pool ( Figure 3A) . Therefore, deletion of SHMT2 or MTHFD1L will prevent one-carbon units produced in the mitochondria from contributing to the cytoplasmic pool. In contrast, MTHFD1L null cells should still have mitochondrial THF-conjugated one-carbon units available for reactions requiring these cofactors, whereas SHMT2 null cells should not. Interestingly, unlike SHMT2 deletion, loss of MTHFD1L did not impact mitochondrial respiration, mitochondrial protein levels, or low glucose sensitivity, and only resulted in modest effects on overall proliferation that differed between individual clones ( Figures 3F and 3G ). These results indicate that depletion of the mitochondrial one-carbon pool, and not flux of one-carbon units from the mitochondria to the cytoplasm, is responsible for the SHMT2 knockout phenotype.
Disruption of SHMT2 would be predicted to result in the depletion from the mitochondria of both its immediate product, 5,10-Me THF, and 10-formyl THF, the product of a downstream reaction catalyzed by the enzymes MTHFD2 and MTHFD2L ( Figure 3A) . To further refine which of these cofactors are most likely to be responsible for the observed phenotypes upon SHMT2 deletion, we used CRISPR/Cas9-mediated techniques to generate Jurkat cell lines in which MTHFD2, MTHFD2L, or both enzymes were deleted (+sgMTHFD2_1 and 2 or +sgMTHFD2L_1 and 2). Loss of MTHFD2 and MTHFD2L was verified by immunoblotting ( Figure 3H ). MTHFD2L null cells retained wild-type levels of oxygen consumption and mitochondrially translated proteins, whereas MTHFD2 null cells exhibited a slight reduction in these phenotypes compared to SHMT2 null cells ( Figures 3H and 3I ). Importantly, MTHFD2/2L double knockout cells exhibited a significant reduction in oxygen consumption and loss of mitochondrially encoded proteins, on the scale of that observed upon SHMT2 deletion ( Figures 3H and  3I ). These results implicate 10-formyl THF as a relevant cofactor lost in SHMT2 null cells that can potentiate the observed mitochondrial defects. Consistent with these findings, of those enzymes that interconvert one-carbon units in the mitochondria and cytosol, only SHMT2 scored in the original genetic screen.
Restoration of One-Carbon Units to the Mitochondria Is Required to Rescue Mitochondrial Defects Observed upon SHMT2 Deletion Addition of exogenous formate to cell culture media has been shown to rescue defects of one-carbon metabolism arising from combined serine starvation and glycine excess (Labuschagne et al., 2014) . Formate can react with THF to generate 10-formyl THF in the cytoplasm (catalyzed by MTHFD1), and formate should be able to diffuse into the mitochondrial matrix, where it can contribute to the mitochondrial one-carbon pool via an analogous reaction (catalyzed by MTHFD1L; Figure 3A) . Indeed, formate addition to SHMT2 null cells was able to restore defects in mitochondrial respiration, mitochondrially encoded proteins, and proliferation in both high and low glucose ( Figures  4A-4D ). The effect of formate addition was dose dependent, as addition of less than 500 mM formate did not restore expression of mitochondrially encoded proteins ( Figures 4E and S5 ). These data are consistent with our observation that SHMT2 null MCF10DCIS.com cells remain deficient in mitochondrially encoded proteins when grown as tumors in vivo ( Figure S4M ), (C and F) Above: proliferation of Jurkat cells or clones expressing the indicated sgRNAs and cDNAs modifying SHMT1 and SHMT2 (C) or SHMT2 and MTHFD1L (F). Below: data from above, normalized to the 10 mM glucose condition for each cell line. Cells were grown for 5 days in media initially containing 10 mM (high glucose) or 1.5 mM glucose (low glucose). We then asked what would be the effect of specifically preventing exogenous formate from contributing to the mitochondrial pool. We therefore deleted MTHFD1L via CRISPR/ Cas9-mediated techniques in SHMT2 null Jurkat cells and verified MTHFD1L loss in single clones ( Figure 4C ). Jurkat cells deficient in both SHMT2 and MTHFD1L exhibited deficiencies in mitochondrial respiration, mitochondrially encoded proteins, and low glucose sensitivity, which were generally more severe than SHMT2 null cells ( Figures 4C, 4D , and 4F). These results further indicate that that upon SHMT2 deletion, cytoplasmic formate production can only slightly compensate via MTHFD1L for loss of the mitochondrial pool. This result may be due to cytoplasmic reactions capturing the majority of THF-conjugated one-carbon units and the relative inefficiency of formate import into the mitochondria and its incorporation into 10-formyl THF by MTHFD1L ( Figure 3A) . Indeed, the K m of MTHFD1L for formate has been measured as 150 mM in the presence of THF-pentaglutamate (Walkup and Appling, 2005) , below the $15 mM formate concentrations observed in the cytoplasm (Lamarre et al., 2012) . Importantly, treatment of cells lacking both MTHFD1L and SHMT2 with formate failed to restore mitochondrially encoded protein expression and mitochondrial respiration ( Figures 4C  and 4D) . These data further demonstrate that the defects in mitochondrial metabolism observed upon SHMT2 deletion are the result of a deficiency in the mitochondrial one-carbon pool.
SHMT2 Null Cells Are Unable to Maintain Formylmethionyl-tRNA Pools in Mitochondria
We next considered whether a specific reaction occurring in the mitochondria could explain the phenotypes observed upon SHMT2 deletion. While several reactions utilize THF-conjugated cofactors, apart from the enzymes of one-carbon metabolism, only one such reaction has been demonstrated to occur in the mitochondria. The mitochondrial methionyl-tRNA formyltransferase (MTFMT) utilizes mitochondrial 10-formyl THF to produce a modified tRNA, fMet-tRNA Met (Dickerman et al., 1967) . This modified tRNA is specifically utilized to initiate translation in prokaryotes and in eukaryotic mitochondria, but is not required for cytoplasmic translation (Kozak, 1983) . Individuals with compound heterozygous mutations in MTFMT exhibit Leigh syndrome and OXPHOS deficiency (Tucker et al., 2011) . Fibroblasts derived from these patients exhibit an accumulation of Met-tRNA Met , while in MTFMT-proficient fibroblasts the fMet-tRNA Met species predominates (Tucker et al., 2011) .
We therefore hypothesized that cells with defects in mitochondrial one-carbon metabolism would become depleted of the 10-formyl THF cofactor and be unable to perform the MTFMT reaction, resulting in decreased mitochondrial translation and the production of proteins lacking an N-terminal formylmethionine ( Figure 5A ). Mitochondrially encoded tRNAs charged with formylmethionine experience a mobility shift compared to methionine-charged or uncharged tRNAs upon polyacrylamide gel electrophoresis. Moreover, fMet-tRNA Met species are relatively resistant to Cu 2+ -induced hydrolysis compared to tRNAs charged with methionine, further permitting distinction between the two tRNA species ( Figure 5A ). Using these methods, we observed that SHMT2 null cells exhibited substantial loss of mitochondrial fMet-tRNA Met and accumulation of the non-formylated Met-tRNA Met precursor, a phenotype rescued by re-expressing an SHMT2 cDNA ( Figure 5B ), similar to MTFMT-deficient patient fibroblasts (Tucker et al., 2011 Figure S6 ). Consistent with their effect on the levels of mitochondrially translated proteins ( Figures 3H and  4C ), co-deletion of SHMT2 and MTHFD1L resulted in a slightly more severe loss of fMet-tRNA Met than that observed upon SHMT2 deletion, co-deletion of MTHFD2 and MTHFD2L resulted in loss of fMet-tRNA Met similar to that observed upon SHMT2 deletion, and deletion of MTHFD2 alone resulted in a less severe loss of fMet-tRNA Met species ( Figures 5C and 5D ). These findings are consistent with the hypothesis that mitochondrial one-carbon metabolism is required to maintain respiration through supporting production of mitochondrial formylmethionyl-tRNAs.
Maintenance of Mitochondrial Protein Levels Requires Minimal SHMT2 Expression
Mitochondrial one-carbon metabolism is one of the most highly activated pathways in transformed tissues, leading to the hypothesis that its suppression would have anti-tumor effects (Nilsson et al., 2014; Ye et al., 2014) , and reduced SHMT2 expression has been observed in aging fibroblasts concomitant with a loss of oxygen consumption, indicative of an additional role in aging tissues (Hashizume et al., 2015) .
We were therefore interested in asking whether physiologic fluctuations in SHMT2 expression or partial suppression, such as that which might be achievable by a small molecule inhibitor, could impact mitochondrial function via the mechanism described above. We generated a lentivirus encoding the SHMT2 cDNA under the control of a doxycycline inducible promoter and stably infected SHMT2 null Jurkat cells (Jurkat DOXi SHMT2). When cultured in the absence of doxycycline, Jurkat DOXi SHMT2 cells expressed barely delectable levels of SHMT2, and addition of doxycycline resulted in restoration of SHMT2 protein levels ( Figure 6A ). However, even the minimal level of leaky SHMT2 expression exhibited in the absence of doxycycline was sufficient to maintain expression of mitochondrially encoded proteins, and additional SHMT2 expression did not further impact the expression of mitochondrially translated proteins ( Figure 6A) . Similarly, withdrawal of doxycycline from Jurkat DOXi SHMT2 cells previously treated with doxycycline resulted in a substantial loss of SHMT2 over 72 hr without impacting mitochondrially translated protein levels ( Figure 6B ). Furthermore, suppression of SHMT2 by RNAi, while leading to a substantial reduction in SHMT2 protein levels, did not impact the levels of mitochondrially translated proteins ( Figure 6C ). These results demonstrate that near-complete loss of SHMT2 activity would be required to limit the expression of mitochondrially encoded proteins.
DISCUSSION
Here, we describe how disruption of the mitochondrial onecarbon pool results in defects in mitochondrial respiration, the proper translation of mitochondrial proteins, and the maintenance of formylmethionyl-tRNAs utilized to initiate mitochondrial translation. Interestingly, previous experiments exploring the role of SHMT2 using RNAi-mediated suppression did not observe these effects (Kim et al., 2015) , consistent with our observation that low levels of SHMT2 protein are sufficient to restore translation of mitochondrial proteins. Our findings are even more surprising given results from studies using MTHFD2 knockout mouse models and analogous S. cerevisiae mitochondrial C(1)-tetrahydrofolate (C(1)-THF) synthase mutants, which demonstrate that MTHFD2/MIS1 deletion does not impact the translation of mitochondrial proteins (Di Pietro et al., 2002; Li et al., 2000) . While the presence of MTHFD2L may rescue the effects of MTHFD2 deletion on mitochondrial translation in the mouse, S. cerevisiae only has one gene encoding the mitochondrial MTHFD2 homolog, MIS1. Furthermore, deletion of MIS1 results in loss of the fMet-tRNA Met species in S. cerevisiae without impacting mitochondrial translation, leading the authors to conclude that initiation of mitochondrial translation in S. cerevisiae does not require Met-tRNA Met formylation due to promiscuity of the mitochondrial translation initiation factor (Li et al., 2000) . Therefore, species-specific differences in the utilization of fMet-tRNA Met to initiate mitochondrial translation may alter the effect of SHMT2 deletion across eukaryotes. The observation that MTFMT compound heterozygotes exhibit Leigh syndrome with OXPHOS deficiency is the clearest evidence that MTFMT, and by extension mitochondrial one-carbon metabolism as described here, is required for proper mitochondrial translation (Haack et al., 2014; La Piana et al., 2017; Tucker et al., 2011) . A recent study of cells derived from patients with MTFMT loss of function has further refined the impact of its loss, arguing that the effect on translational efficiency is subunit specific, and that there may be an additional downstream effect on the stability of proteins that are translated but lack the N-terminal formylmethionine (Hinttala et al., 2015) . Therefore, the observed reduction in oxygen consumption may be a compound effect on translational efficiency, protein stability, and complex formation. However, our results do not exclude the possibility that there exist other mitochondrial reactions requiring one-carbon units to support mitochondrial translation or protein levels. Indeed, the reduction in OCR and mitochondrially encoded proteins observed upon co-deletion of MTHFD2 and MTHFD2L is similar, but not identical, to SHMT2 deletion (Figures 3H and 3I) , while fMet-tRNA Met levels are similarly affected ( Figure 5D ). Eukaryotic cells maintain parallel pathways for generating THF-conjugated one-carbon units in the cytoplasm and mitochondria (Appling, 1991 THF-conjugated one-carbon units occur in the cytoplasm or nucleus, including thymidylate synthase and phosphoribosylglycinamide formyltransferase reactions involved in nucleotide biosynthesis. Because one-carbon units for these reactions can be provided by cytoplasmic enzymes, the rationale for maintaining separate mitochondrial enzymes is unclear. Prior work has demonstrated that NADPH production by the mitochondrial pathway and the efficiency of the mitochondrial reactions in providing one-carbon units for cytoplasmic reactions are important functions of this compartment Ye et al., 2014) . Our results are consistent with support of proper mitochondrial translation via Met-tRNA Met formylation as being an additional key function of one-carbon metabolism across multiple mammalian cell types. However, maintenance of mitochondrially encoded proteins is likely to require only limited mitochondrial one-carbon pools. As such, support of N-terminal formylmethionine incorporation during mitochondrial translation is unlikely to underlie the increases in mitochondrial onecarbon metabolism observed in transformed tissues (Mejia and MacKenzie, 1985; Nilsson et al., 2014) . Moreover, anti-cancer models that delete SHMT2 as a proxy for drug treatment may overestimate the anti-cancer impact of SHMT2 perturbation, as SHMT2 deletion will inhibit mitochondrial translation, whereas the effects of drug treatment may not achieve the depletion of mitochondrial one-carbon units required to produce the same phenotype. By identifying genes required for optimal proliferation in glucose-limiting conditions, our work also provides insight into additional genes or pathways required for ETC function, and the relative impact of inhibiting individual mitochondrial complexes. Interestingly, components of Complex I scored more significantly than components of Complexes III-V in the CRISPR/Cas9-based screen reported here ( Figure S1 ), whereas our prior work using short hairpin RNA (shRNA)-mediated gene suppression identified members of all four complexes equally (Birsoy et al., 2014) . While subtle differences in the impact of Complex I versus Complexes III-V inhibition may explain this discrepancy, prior work supports the notion that cells can tolerate loss of most Complex I proteins (Stroud et al., 2016) , in contrast to the core components of Complexes III-V Wang et al., 2017) . These differences in the requirement of individual subunits for cell viability could permit differential selection and scoring in genetic screens that utilize complete gene knockouts, as opposed to partial gene suppression.
Given the results presented, it is interesting to consider whether regulation of mitochondrial one-carbon metabolism in vivo can modulate OXPHOS via impacting mitochondrial translation. Our results indicate that flux through SHMT2 plus MTHFD2/2L should be required to support mitochondrial translation in vivo. In contrast, flux through MTHFD1L may only partially support the mitochondrial one-carbon pool in the event that cytosolic formate levels are high, particularly given the high K m of the enzyme for formate (Walkup and Appling, 2005) , and it is not clear in what context such high concentrations would be expected. Indeed, SHMT1 knockout mice do not exhibit any overt phenotypes (MacFarlane et al., 2008) , which one would expect if normal mitochondrial function were supported via cytoplasmic pools. Therefore, we would expect that tissues in which SHMT2 or MTHFD2 and MTHFD2L are expressed at very low levels might regulate mitochondrial metabolism through activation of SHMT2 or MTHFD2/2L. Based on analysis of publicly available data, SHMT2 expression is very low in the testes, breast ductal epithelium, and several CNS tissues, whereas MTHFD2/2L is very low in the cerebral cortex and basal ganglia. Whether expression of these genes is sufficiently low as to limit mitochondrial translation, and therefore whether activation of these enzymes in such tissues can regulate mitochondrial metabolism, are unanswered questions for future work.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Richard Possemato (richard.possemato@nyumc.org). Plasmids novel to this study and corresponding sequences have been deposited at Addgene (http://www.addgene.org/).
EXPERIMENTAL MODEL AND SUBJECT DETAILS

Cell lines
Cell lines were obtained from the following sources: Jurkat, TT, and MCF-7 from ATCC, MCF10DCIS.com cells from the Karmanos Cancer Center, Michigan, and KP murine non-small cell lung carcinoma cells from Thales Papagiannakopoulos.
Animals
Tumors were initiated into 4-8 week old female NOD.CB17 Scid/J mice orthotopically in the mouse mammary gland by implanting 500,000 MCF10DCIS.com cells in 33% matrigel into the 4 th murine mammary fat pad in a total volume of 25 mL. All experiments involving mice were carried out with approval from the Committee for Animal Care and under supervision of the Department of Comparative Medicine at MIT and NYU Langone Medical Center.
METHOD DETAILS
Cell Culture Cells were tested to be mycoplasma free by PCR based methods and authenticity verified by STR profiling (Duke University) for cell lines not ordered and used within one year. Cells were cultured in RPMI supplemented with 10% IFS (Sigma) and penicillin/ streptomycin, except MCF10DCIS.com cells which were cultured in 50:50 DMEM and F12 media with 5% horse serum (Invitrogen) and penicillin/streptomycin.
CRISPR-Based Screen
The metabolism-focused sgRNA library of 30,000 sgRNAs (10 sgRNAs per gene) was designed and performed as previously described . Oligonucleotides for the sgRNAs were synthesized by CustomArray and amplified by PCR. Jurkat cells were infected with the sgRNA library at an MOI of 0.5, puromycin selected for 3 days, and an initial gDNA sample was collected. Cells were grown in nutrostats (Birsoy et al., 2014) set to high (10 mM) or low (0.75 mM) glucose for 14 days, and a final gDNA sample collected. Pool deconvolution was accomplished by deep sequencing and sgRNA abundance calculated by previously described methods . We then computed the differential abundance of each sgRNA in high glucose versus low glucose and combined these sgRNA scores to arrive at a gene-level by taking the median of 10 sgRNAs targeting each gene. These values are reported in the Table S1 and in Figure 1B .
Generation of Knockout Cell Lines and cDNA Overexpression Cell Lines, and shRNA suppression
The SHMT2 open reading frame (WT or with a K280A mutation) was cloned into pMXS-IRES-Blast by direct ligation of dsDNA GeneBlocks (IDT) harboring silent mutations in the sgRNA targeting sites. sgRNAs were cloned into pLentiCRISPR, pLentiCRISPR-v2, or pSECB linearized with BsmBI with Quick ligase (New England Biolabs; M2200). These vectors along with lentiviral packaging vectors Delta-VPR and CMV VSV-G were transfected into HEK293FT cells by polyelthylenimine (Polysciences; 60 mg/mL) mediated transfection. Similarly, for overexpression cell lines, cDNA vectors along with retroviral packaging pCL-ampho were transfected into HEK293FT cells. Media was changed 24 hr after transfection and the virus-containing supernatant was collected 48 hr after transfection. Virus was passed through a 0.45 mm filter and stored at À80 C or used immediately. Target cells in 6-well tissue culture plates were infected in media containing 2 mg/ml polybrene by spin infection at 2,250 rpm for 30 min. 24 hours post-infection, virus was removed and cells were selected with puromycin or blasticidin. For pLentiCRISPR-infected cells, after selection single cells were plated into the wells of a 96-well plate. Cells were grown for 2-3 weeks, and the resultant colonies were expanded and screened for loss of the relevant protein by immunoblotting.
For SHMT2 suppression by RNAi, lentiviral shRNAs vectors were obtained from The RNAi Consortium (TRC) collection of the Broad Institute, The TRC website is: https://portals.broadinstitute.org/gpp/public/. The TRC#s for the shRNAs used are: shLUC, TRCN0000072246; shSHMT2, TRCN0000238795. To restore SHMT2 expression upon shRNA mediated suppression, a codon optimized SHMT2 cDNA was obtained (IDT gene block) and cloned into pMXS-IRES-BLAST.
The pSECB vector was made by gibson assembly, inserting the blasticidin resistance open reading frame in place of cre recombinase from the vector pSECC (Sá nchez-Rivera et al., 2014).
Immunoblotting
Cells were rinsed once in ice-cold PBS and harvested in a lysis buffer containing 50 mM HEPES, pH 7.4, 40 mM NaCl, 2 mM EDTA, 50 mM NaF, 10 mM pyrophosphate, 10 mM glycerophosphate, protease inhibitors (Roche) and 1% Triton X-100. Protein concentrations were measured by the Bradford method or BCA Protein Assay (Pierce) and 15 mg of total lysates were resolved by SDS-PAGE (4%-12% gel) and analyzed by immunoblotting as described (Minton et al., 2016) .
Proliferation Assays
Direct cell counts were carried out by plating cells in triplicate in 12-well plates at 10,000 cells per well in 2 mL of media containing 1 mM or 10 mM glucose. For formate treatment, 0.5 mM sodium formate was added for three days prior to imitating proliferation assays. After 5 days, cells were counted using a Beckman Z2 Coulter Counter with a size selection setting of 8 to 30 mm.
Metabolite Profiling 5 million Jurkat cells were cultured in high or low glucose conditions for 5 days prior to metabolite extraction. Cells were rapidly washed with cold 0.8% saline, and metabolites were extracted with 80% ice-cold methanol and dried by SpeedVac. Endogenous metabolite profiles were obtained using liquid chromatography-mass spectrometry (LC-MS) as previously described . Metabolite levels (n = 4 biological replicates) were normalized to protein content.
Oxygen Consumption Measurements
Oxygen consumption of cells was measured using an XFe24 Extracellular Flux Analyzer (Seahorse Bioscience). For suspension cells, seahorse plates were coated with Cell-TAK (Corning; 0.02 mg/mL in 0.1 mM NaHO 3 ) for 20 min. Then 200,000 cells were attached to the plate by centrifugation at 1,000g, without brakes for 5 min. For adherent cells, 30,000 to 80,000 cells were plated the night before the experiment. RPMI was used as the assay media for all experiments with 1 mM glucose (low glucose) or 10 mM glucose (high glucose) in the presence of 2 mM glutamine without serum. For basal oxygen consumption measurements, cell number was used for normalization.
Mitochondrial DNA copy number, mass, membrane potential, and expression For copy number, total DNA was isolated and qPCR was performed. Alu repeat elements were used as controls. Primers used were: ND1 forward and reverse, CCCTAAAACCCGCCACATCT and GAGCGATGGTGAGAGCTAAGGT; ND2 forward and reverse, TGTTGGTTATACCCTTCCCGTACTA and CCTGCAAAGATGGTAGAGTAGATGA; Alu forward and reverse, CTTGCAGTGAGCCGA GATT and GAGACGGAGTCTCGCTCTGTC.
For mitochondrial mass measurements, 1 3 10 6 cells were incubated with 75 nM Mitotracker Green FM (Invitrogen; M7514) in RPMI for 1 hr at 37c C. Cells were then centrifuged at 1,000g for 5 min at 4c C and the overlying media removed. Cells were kept on ice, washed once with PBS, and resuspended in fresh PBS for flow cytometry analysis of live cells. The mean Mitotracker Green fluorescence intensity was used as a measure of relative mitochondrial mass.
For mitochondrial membrane potential, 1 3 10 5 cells were incubated with 200 nM tetramethylrhodamine, methyl ester, perchlorate (TMRE) stain (Life Technologies; T668) in RPMI for 20 min at 37c C, washed once with PBS, and resuspended in fresh PBS for flow cytometry analysis of live cells. For FCCP treatment, cells were incubated with 20 mM FCCP for 10 min prior to adding TMRE stain. The mean TRME fluorescence intensity was used as a measure of relative mitochondrial membrane potential.
The following primers were used to analyze the expression of mitochondrially encoded genes by qPCR are provided in Table S2 .
Mitochondrial and Cytoplasmic Translation Assay
Mitochondrial or cytoplasmic protein translation was assessed by labeling with 35 S-methionine/ 35 S-cysteine (EXPRE35S35S Protein Labeling Mix; Perkin Elmer Life Sciences). 5 3 10 6 cells were incubated in RPMI media lacking methionine for 6 hours prior to cycloheximide (Sigma, C7698) treatment or 30 minutes prior to emetine (Millipore, 324693) and chloramphenicol (Sigma, C0378) treatment. The inhibitors (100 mg/ml) were added and cells were incubated for 15 minutes. 55 mCi 35 S-methionine/ 35 S-cysteine was then added to media and cells were incubated at 37 C for an additional 2 hours (cycloheximide treated samples) or 1 hour (chloramphenicol and emetine treated samples). Cells were washed with ice-cold PBS and RIPA lysis buffer was added. Mitochondrial proteins (60 mg) were analyzed by SDS-PAGE using 16% tris-glycine gel in tris-glycine running buffer, and cytoplasmic proteins (20 mg) using 4%-12% bis-tris gel in MES running buffer. Total protein levels were assessed by Coomassie blue staining (0.1% Coomassie blue in 7% acetic acid and 40% methanol), and 35 S labeled proteins were assayed by autoradiography using BioMax MR film (Sigma, Z350370) or phosphor imaging screen .
Northern blot analysis of mitochondrial Mef/fMet-tRNA Met Analysis of mitochondrial tRNAs was performed essentially as described in Kö hrer and Rajbhandary (2008) with the following details and modifications: 2.5 3 10 7 cells were lysed in TRIzol (Life Technologies, 15596026) and total RNA was extracted according to the manufacturer's instructions except that RNA pellet was washed using 75% ethanol containing 10 mM sodium acetate (pH 4.9). Aqueous phase of each sample was divided into 3 parts. After isopropanol precipitation and ethanol wash, each RNA pellet was subject to the following treatments. The first sample was resuspended in 10 mM sodium acetate (pH 4.9) and incubated at 37 C for 30 minutes (control treatment). The second sample was resuspended in 200 mM sodium acetate (pH 4.9) containing 10 mM CuSO 4 and incubated at 37 C for 30 minutes to selectively deacylate Met-tRNA Met (Guillon et al., 1992) . The reaction was terminated by adding 10 mM EDTA. The third sample was resuspended in 100 mM Tris-Cl (pH 9.6) and incubated at 65 C for 5 minutes, followed by incubation at 37 C for 1 hr. This treatment deacylates all amino acid-charged tRNAs (Kö hrer and Rajbhandary, 2008) . Following treatment, the samples were ethanol-precipitated and redissolved in 10 mM sodium acetate (pH 4.9). The RNA concentration was measured by a Nanodrop spectrophotometer. Acid-urea PAGE and Northern blotting were then performed as previously described with slight modifications (Kö hrer and Rajbhandary, 2008; Nilsson et al., 2014) . Briefly, 5-7 mg of total RNA was separated on an 8.5% acid-urea polyacylamide gel (17.1W x 32.5H cm, 0.4 mm thick) using a sequencing gel apparatus (Model SA, GIBCO-BRL). After running at 500 V for 14-18 hours, RNAs were transferred onto positively charged nylon membrane (Hybond-N + #RPN303B, GE Healthcare). The membrane was baked at 70 C for 1.5 hours and then prehybridized at 42 C for 6 hours. The probe specific for mitochondrial tRNA Met (5 0 -TAGTACGGGAAGGGTATAA-3 0 ) was labeled at 5 0 end with 32 P-g-ATP (PerkinElmer) using T4 polynucleotide kinase (NEB). The membrane was hybridized with the labeled probe at 42 C for 20-24 hours, followed by two washes with 6x SSC and one wash with 4x SSC at room temperature (each wash for 10 minutes). The membrane was then exposed to a BioMax MR film (Kodak) to visualize bands at À80 C for 1-3 days.
QUANTIFICATION AND STATISTICAL ANALYSIS
Experiments were repeated at least three times with the following exceptions, the CRISPR screen ( Figures 1A, 1B , and S1), which was performed once. P values reported in the figures are the result of heteroscedastic Student's t tests and distributions assumed to follow a Student's t distribution. These assumptions are not contradicted by the data. No samples or animals were excluded from analysis and sample size estimates were not used. The number of independent biological replicates (n) are indicated in the figure legend and represent replicate measurements from distinct samples. For immunoblots and autoradiograpy, the reported images are representative of at least three independent experiments. Studies were not conducted blind.
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